Literature DB >> 2850546

Giant duodenal ulcer: the hepatic intra-arterial chemotherapy variant.

E Goldin1, T Peretz, E Libson.   

Abstract

Giant duodenal ulcers are extensive ulcers, more than 2.5 cm in diameter, that involve a large portion of the duodenal bulb. These atypical duodenal ulcers create serious problems to the patient and the physician, are frequently complicated by bleeding and penetration, and have a high mortality rate. Most of the reported cases were classified as a severe variant of the common peptic ulcer disease, others were associated with the Zollinger Ellison syndrome. We report here four patients with giant duodenal ulcers but with a different and definitive aetiology: hepatic intra-arterial chemotherapy infusion for liver metastase or primary hepatocellular carcinoma.

Entities:  

Mesh:

Year:  1988        PMID: 2850546      PMCID: PMC2428865          DOI: 10.1136/pgmj.64.752.431

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  9 in total

1.  Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.

Authors:  D Hohn; J Melnick; R Stagg; D Altman; M Friedman; R Ignoffo; L Ferrell; B Lewis
Journal:  J Clin Oncol       Date:  1985-01       Impact factor: 44.544

2.  Giant duodenal ulcers.

Authors:  R L Eisenberg; A R Margulis; A A Moss
Journal:  Gastrointest Radiol       Date:  1978-02-23

3.  Giant duodenal ulcer: a dangerous variant of a common illness.

Authors:  T W Klamer; M M Mahr
Journal:  Am J Surg       Date:  1978-06       Impact factor: 2.565

4.  Percutaneous hepatic arterial infusion (HAI) of mitomycin C and floxuridine (FUDR): an effective treatment for metastatic colorectal carcinoma in the liver.

Authors:  Y Z Patt; G M Mavligit; V P Chuang; S Wallace; S Johnston; R S Benjamin; M Valdivieso; E M Hersh
Journal:  Cancer       Date:  1980-07-15       Impact factor: 6.860

5.  Acute cholecystitis associated with hepatic arterial infusion of floxuridine.

Authors:  P C Lafon; K Reed; D Rosenthal
Journal:  Am J Surg       Date:  1985-12       Impact factor: 2.565

6.  A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump.

Authors:  C M Balch; M M Urist; S J Soong; M McGregor
Journal:  Ann Surg       Date:  1983-11       Impact factor: 12.969

7.  Gastroduodenal ulcerations in patients receiving selective hepatic artery infusion chemotherapy.

Authors:  J J Wells; T T Nostrant; J A Wilson; J W Gyves
Journal:  Am J Gastroenterol       Date:  1985-06       Impact factor: 10.864

8.  Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liver.

Authors:  Y Z Patt; V P Chuang; S Wallace; R S Benjamin; R Fuqua; G M Mavligit
Journal:  Cancer       Date:  1983-04-15       Impact factor: 6.860

9.  Penetrating duodenal ulcer associated with an operatively implanted arterial chemotherapy infusion catheter.

Authors:  M L Crowley
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.